Back to News
Market Impact: 0.2
Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Source: gurufocus.com
Legal & LitigationHealthcare & Biotech
Capricor Therapeutics investors were notified of a September 28, 2026 deadline to apply as lead plaintiff in a class-action lawsuit. The notice signals ongoing securities-litigation risk for the biotech company, though the article provides no details on allegations, potential damages, or operational impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.35
Ticker Sentiment
CAPR-0.85
More News
- J&J's potential 'game-changer' drug — plus, what Microsoft's mass buyouts mean
- ‘Imposed significant financial harm’: 20 states join the FTC in suing Dollar General for ‘deceptive pricing practices’ despite ‘corporate knowledge’
- The excitement around Moderna’s cancer vaccine is cooling. Here’s why.
- Cramer: I asked some tech insiders what to buy. They surprisingly said this drug stock
- Anthropic’s dual-class share structure borrows ideas from Mark Zuckerberg, Elon Musk—and the New York Times
- Moderna CEO Sees Cancer Vaccines Working Beyond Melanoma
From AllMind Research
- AllMind Platform Feature Updates - Fall 2026
- AI Credit Covenant Monitoring: From Clause to Review
- AI-Led Expert Interviews vs. Transcript Libraries
- How to Evaluate AI Report Writers for Financial Analysis
- Augmented Intelligence: AllMind, Elevate Human Judgement With an Accessible, Powerful, Data-Driven Financial AI Toolkit